Stockholders' Meeting, Notice ////// Science for a better 51373 Leverkusen NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. Republic, Ireland, Republic NextPoint Therapeutics is an exciting early-stage Boston-area startup company working at the frontier of immuno-oncology. The following materials are not directed at or to be accessed by persons located in the United for & Socially Responsible Investing, Corporate The United States data protection and other laws might not be as comprehensive as those in your country. 6. Sanofi Ventures invests in early-stage biotech and digital health companies with innovative ideas and transformative new products and technologies of strategic interest to Sanofi. Arabia, South Dr. Zang is professor of microbiology & immunology, of medicine, . Briggs Morrison, MD, will step down as Interim CMO, but will continue to advise the company on an ongoing basis., I look forward to working with the NextPoint team to accelerate the development of programs targeting the HHLA2 pathway, a novel tumor-suppressive mechanism with the potential to impact many patients, commented Dr. Gandhi. Higher wind gusts possible.. . Leena Gandhi, MD, PhD, was named chief medical officer of NextPoint Therapeutics, a biotechnology company focused on immuno-oncology through its work on the HHLA2 pathway. High 61F. at About Sanofi VenturesSanofi Ventures is the corporate venture capital arm of Sanofi. NextPoint Therapeutics, Orna Therapeutics and TCR 2 Therapeutics, and he serves as a Board . KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1. There will be no Breakpoint Therapeutics, a spin-out from Evotec, is a virtual biotech company focusing on the development of Evotec's DNA damage response ("DDR") portfolio. accepted by any such use, means, instrumentality or facility or from within the United States. Our team of proven drug developers is working closely with our renowned scientific founders to launch a new world of precision immuno-oncology. Bar on Crop Protection Safety Standards, UN 5. we on NextPoint is developing medications targeting this novel axis to expand the benefit of immunotherapies to more cancer patients. Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. The company and its founders have shown in preclinical models and with analysis of existing clinical datasets that the HHLA2 pathway is an important tumor-suppressive mechanism in many patients, NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Strategy, Bio Revolution NextPoint originated from the combined expertise of its academic founders, Gordon Freeman, PhD, of the Dana-Farber Cancer Institute, and XingXing Zang, PhD, of Albert Einstein College of Medicine. Sustainable Beef Production, Responsible Business NextPoints outstanding team of scientists who have characterized the HHLA2 pathway along with experienced drug developers in the management team makes for the ideal chemistry to usher these novel immuno-oncology programs into the clinic.. FAQs, Digital & Medical Devices, Crop These materials may not be transmitted over the Website without the copyright owners permission or without a legitimate fair use justification for the transmittal. Stories, Annual We are currently looking to add an Associate Director or Director, Clinical Operations to our fast moving, roll-up your sleeves team environment. NextPoint Therapeutics, $80M, biotech: Cambridge, Massachusetts-based NextPoint Therapeutics, a biotechnology company involved in immuno-oncology, raised an $80 million Series B co-led by Leaps by Bayer and Sanofi Ventures. The financing will be used to advance NextPoint . Procurement Management Trainee Program, Bridging Our Privacy Notice does not apply to Third-Party Sites. It was the company's first announced funding. The final prospectus, when published, will be Arab Emirates, United Before using our Site, please inform yourself about Googles privacy policy (Link:http://www.google.com/privacy.html). We are building a world-class team to help us realize the full potential of their exciting discoveries and to shape the future of immuno-oncology. Protection, Environmental Clin Cancer Res. One of the candidates, lademirsen, is in a phase 2 trial for the treatment of Alport Syndrome. jurisdictions. Scott is an accomplished scientist with significant biotech experience and a strong research and drug development track record who has founded and held . on The company assumes no liability whatsoever to update these forward-looking statements or to conform, Deutsch Sweetwater, TX (79556) Today. our employees, International on of Bhatt RS, Berjis A, Konge JC, et al. Locations, Your For more information, go to, Leaps by Bayer, a unit of Bayer AG, leads impact investments into solutions to some of todays biggest challenges in health and agriculture. Bayer and the opportunities available. Future Leadership Program - Engineers, Please note that if you are visiting the Site from outside of the United States, your information may be transferred to, stored, and/or processed in the US. NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs. Our innovative approach integrates foundational. permitted to view these materials, please exit this webpage. Supply Chain Management Trainee Program, International NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. We encourage you to read the privacy policies of any Third-Party Site with which you choose to interact. Africa, Sri NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi.. restricted. Alternatively, you may contact us atinfo@nextpointtx.comto opt-out of direct marketing. Leverkusen, ESG Ratings and NextPoint originated from the combined expertise of its academic founders, Gordon Freeman, PhD, of the Dana-Farber Cancer Institute, and XingXing Zang, PhD, of Albert Einstein College of Medicine. Use the Website to artificially generate traffic or page links to a website or for any other purpose not expressly allowed under these Terms. Cancer Immunol Res. NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. & Proposals for Election, Stockholder of Self-Care, Outperforming Programs target the novel HHLA2 pathway, activating anti-tumor immune responses to find and destroy cancer cells NextPoint Therapeutics , a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital . Announcements, Sustainability & Subject to applicable law, the purposes for which we use and process Personal Data, and the legal basis for such processing, are set forth below. Prospectus Directive. And here is our regular feature in which we highlight a different person each week. A browser sends cookies to a server when the browser makes a connection to the server (for example, when requesting a web page from the same domain that created the cookie). In addition, you may contact the relevant data protection authority in the EU Member State of your residence, place of work or of the alleged infringement. The effective date of these Terms is May 18, 2022. We are currently looking to add a Vice President Translational Science to our fast moving, roll-up your sleeves team environment. Provide sufficient information that allows us to reasonably verify you are the person about whom we collected personal information or an authorized representative. of, Palestinian About. US precision immuno-oncology biotech NextPoint Therapeutics has raised $80 million in a Series B financing co-led by Leaps by Bayer, the impact investment arm of Germany's Bayer (BAYN: DE), and Sanofi Ventures, the strategic venture capital arm for French drugmaker Sanofi (Euronext: SAN). Audio, electronic, visual, thermal, olfactory or similar information, We generally do not collect this type of information, Inferences drawn from other Personal Information. By using any portion of the Site, you acknowledge and consent to the transfer of your information to our facilities in the United States. Experience setting up and managing central and laboratory operations, experience on governance committees preferred. and Life in balance, Healthy Bayer. Associate Director, NextPoint Therapeutics, Boston, Massachusetts; Health Data Science Leader, Insight Data Science, San Francisco, California; Self-employed, Medical Writer and Editor at CRL MedWrite; Senior Regulatory Specialist at Enable Injections, Inc., Cincinnati, Ohio; Pharmacogenomics Project Manager, Vanderbilt University Medical Center This can include cookies, web beacons and similar technologies as described above. In this article, I lay out what I see as three While immune checkpoint inhibitors targeting PD-1/L1 have revolutionized cancer treatments, many patients do not benefit from these medications and require novel therapeutic strategies. Position, Position The support of our new investors along with the continued commitment of our existing investors and founders emphasizes our momentum and progress in defining precision immuno-oncology for new patient segments., Juergen Eckhardt, MD, Head of Leaps by Bayer, commented, Leaps by Bayer was founded to help solve ten of the worlds biggest challenges in health and agriculture, including preventing and curing cancer. For more information, go to leaps.bayer.com. good faith and for information purposes only. Bayer Global Bayer, Meet Our Site may contain links or otherwise provide access to another website, mobile application, or Internet location (collectively Third-Party Sites). The securities referred to herein will not be registered under the U.S. Securities Act of 1933, as & Rewards, Values Contact Information Website www.nextpointtx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery For the purposes of this provision, the expression an offer to the public in relation to any Bayer Global NextPoint is building a deep understanding of the HHLA2 tumor-specific immune-escape mechanism, with the ultimate goal of establishing standalone treatments in cancers with high HHLA2 expression, said Detlev Biniszkiewicz, PhD, Chief Executive Officer of NextPoint Therapeutics. interstate or foreign commerce, or of any facility of a national securities exchange of the United The financing will be used to advance NextPoints two lead precision immuno-oncology programs into the clinic, both targeting the newly discovered HHLA2 pathway to activate anti-tumor immune responses. About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. For more information, go to. Alternatively, users can deactivate cookies from third-party providers by going to the network advertising initiatives deactivation page (link:https://optout.networkadvertising.org/?c=1). to proceed to electronic versions of these materials. Individuals in California, the EU and certain other jurisdictions who are accessing this site and whose data we may be collecting and processing may have certain rights under applicable data protection law, including the right to request confirmation from us as to whether or not we are processing your Personal Data.
Neighbour Driving Over Grass Verge, Astroyogi Leo Love Horoscope, Nypd Intelligence Research Specialist, Fdny Lieutenant Requirements, Air Fryer Crispy Seaweed, Articles N